Seattle Genetics, Inc. (SGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
56.66+0.95 (+1.71%)
As of 11:25 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close55.71
Bid56.42 x 200
Ask56.50 x 100
Day's Range55.41 - 57.23
52wk Range26.02 - 57.23
1y Target EstN/A
Market Cap7.96B
P/E Ratio (ttm)-74.16
Avg Vol (3m)770,893
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.com5 hours ago

    [$$] Two Cancer Biotechs See Bullish Insider Buying

    Two biotechs researching cures for cancer saw nearly $70 million in stock purchases from entities controlled by Felix and Julian Baker in September. The Baker brothers bought 659,371 additional shares of Seattle Genetics (SGEN) for $32,544,025, or about $49.36 each, from Sept. 6 through Sept. 13. The Bakers each directly own 107,500 shares, and their 667 LP and Baker Brothers Life Sciences LP entities now hold 4,671,498 shares and 39,388,096 shares, respectively.

  • 3 Biotechs That Could Be M&A Targets
    Motley Fool3 days ago

    3 Biotechs That Could Be M&A Targets

    These three cancer drug stocks could have the best shot at getting acquired.

  • Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
    Insider Monkey5 days ago

    Blue Jay Capital Betting On Big Returns From These Healthcare Stocks

    Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay Capital (named after Canada’s only current Major League Baseball team, the Toronto Blue Jays), Mr. Sinclair founded and ran another healthcare-focused hedge fund Expo Capital Management (named after the former Canadian MLB team the Montreal […]